Sharda Cropchem Ltd Downgraded to Buy on Technical and Valuation Shifts

Technical Trends Shift to Mildly Bullish

The primary catalyst for the rating change stems from a recalibration of the technical grade, which has moved from bullish to mildly bullish. While several weekly and monthly indicators remain positive, a few key signals have moderated, prompting a more cautious stance.

Specifically, the Moving Average Convergence Divergence (MACD) remains bullish on both weekly and monthly charts, supporting underlying momentum. The Know Sure Thing (KST) indicator also continues to signal bullishness across weekly and monthly timeframes. However, the Relative Strength Index (RSI) on the weekly chart has turned bearish, indicating some short-term price weakness or consolidation. Additionally, the Dow Theory on the weekly scale has shifted to mildly bearish, and the On-Balance Volume (OBV) indicator shows mild bearishness weekly, suggesting reduced buying pressure.

Bollinger Bands maintain a mildly bullish stance on both weekly and monthly charts, while daily moving averages remain bullish, reflecting near-term support. Taken together, these mixed signals have tempered the technical enthusiasm, leading to a downgrade in the technical grade and influencing the overall rating adjustment.

Valuation Upgraded to Attractive

In contrast to the technical moderation, Sharda Cropchem’s valuation grade has improved from fair to attractive, bolstering the investment case. The company currently trades at a price of ₹1,026.60, comfortably above its 52-week low of ₹440.05 but below the 52-week high of ₹1,297.80, indicating room for upside.

Key valuation ratios underpin this upgrade: the price-to-earnings (PE) ratio stands at a reasonable 16.37, well below peers such as Bayer CropScience (PE 30.84) and Anupam Rasayan (PE 86.13). The enterprise value to EBITDA ratio is 9.51, signalling efficient earnings relative to enterprise value. The PEG ratio is exceptionally low at 0.12, highlighting strong earnings growth relative to price. Return on capital employed (ROCE) is robust at 24.83%, and return on equity (ROE) is a healthy 16.89%, both indicative of efficient capital utilisation and profitability.

Dividend yield, while modest at 1.17%, adds to the stock’s appeal for income-oriented investors. The price-to-book value ratio of 3.46 further supports the attractive valuation narrative, especially when compared to industry averages. This valuation improvement offsets some technical caution and supports the Buy rating.

Strong Financial Trend with Exceptional Profit Growth

Sharda Cropchem’s financial trend remains very positive, reinforcing confidence in its operational strength. The company reported outstanding quarterly results for Q3 FY25-26, with net profit surging by 365.99% year-on-year to ₹145.12 crores. Profit before tax excluding other income (PBT less OI) grew by 247.21% to ₹157.32 crores, underscoring strong core earnings growth.

Net sales have expanded at an annualised rate of 18.17%, while operating profit has grown at 19.11%, reflecting healthy top-line and margin expansion. The company has declared positive results for seven consecutive quarters, signalling consistent operational momentum. Its debt-to-equity ratio remains negligible at zero, indicating a clean balance sheet and low financial risk.

Return on capital employed (ROCE) for the half-year period reached a peak of 20.85%, further highlighting efficient capital deployment. Over the past year, Sharda Cropchem’s stock has delivered an impressive 86.32% return, vastly outperforming the Sensex’s 5.52% gain. Longer-term returns are even more striking, with 5-year and 10-year returns at 227.20% and 350.86% respectively, compared to Sensex returns of 52.51% and 217.61% over the same periods.

Quality Assessment Remains High

Sharda Cropchem continues to rank among the top 1% of companies rated by MarketsMojo across a universe of over 4,000 stocks. It holds a Mojo Score of 77.0 and a Mojo Grade of Buy, down from a previous Strong Buy. The company is ranked 14th among Small Cap stocks and 44th across the entire market, reflecting strong quality credentials.

Its majority shareholding by promoters provides stability and alignment with shareholder interests. The company’s consistent earnings growth, low leverage, and efficient capital utilisation underpin its high-quality profile. Despite the slight downgrade in technicals, the overall quality remains robust, supporting a positive medium- to long-term outlook.

Comparative Performance and Market Context

When benchmarked against the broader market, Sharda Cropchem’s performance stands out. Over the last one year, the stock’s return of 86.32% dwarfs the Sensex’s 5.52% gain. Even in shorter periods, the stock has shown resilience, with a year-to-date return of 17.42% compared to the Sensex’s negative 8.23%. However, in the very short term, the stock has underperformed, with a one-week return of -9.45% versus the Sensex’s -2.53%, and a one-month return of -12.23% against the Sensex’s -7.20%, reflecting recent volatility and the technical softening.

Despite this near-term weakness, the company’s long-term growth trajectory remains intact, supported by strong fundamentals and an attractive valuation profile. This combination justifies the current Buy rating, albeit with a more cautious technical outlook.

Conclusion: Balanced Outlook with Strong Fundamentals

The revision of Sharda Cropchem Ltd’s investment rating from Strong Buy to Buy reflects a balanced assessment of its current standing. While technical indicators have softened from bullish to mildly bullish, signalling some short-term caution, the company’s attractive valuation, exceptional financial performance, and high-quality metrics provide a solid foundation for continued growth.

Investors should note the stock’s impressive long-term returns and robust profitability, alongside its low leverage and consistent earnings growth. The valuation upgrade to attractive further enhances the investment appeal, suggesting that the stock remains well positioned within the Pesticides & Agrochemicals sector.

Overall, Sharda Cropchem offers a compelling investment proposition for those seeking exposure to a fundamentally strong and well-managed agrochemical company, with the caveat of monitoring technical signals for near-term price action.

Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today